Heparin Sodium Injection

DRUG4 trials

Sponsors

Renmin Hospital of Wuhan University, Haisco Pharmaceutical Group Co., Ltd., Xuanwu Hospital, Beijing, Fuzhou First General Hospital Skin Disease Prevention and Control Hospital

Conditions

Cerebral AngiographyHealthyHeparinizationPrimary PCISTEMIXanthelasma Palpebrarum

Phase 1

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 in Healthy Volunteers

CompletedNCT05742126

Haisco Pharmaceutical Group Co., Ltd.Healthy

Start: 2022-04-11End: 2022-09-15Updated: 2023-02-23

Phase 4

Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy

CompletedNCT06365398

Xuanwu Hospital, BeijingCerebral Angiography, Heparinization

Start: 2018-01-01End: 2022-01-01Updated: 2024-04-15

Unknown Phase

Early Administration of Heparin At FMC for PPCI of STEMI Patients

CompletedNCT05329155

Renmin Hospital of Wuhan UniversityPrimary PCI, STEMI

Start: 2022-07-20End: 2024-08-20Updated: 2025-03-27

Observation of the Effect and Mechanism of Multi Tunnel Minimally Invasive Treatment for Xanthelasma Palpebrarum

Enrolling by invitationNCT06869291

Fuzhou First General Hospital Skin Disease Prevention and Control HospitalXanthelasma Palpebrarum

Start: 2025-02-01End: 2029-02-01Target: 270Updated: 2025-03-11

Related Papers

Safety and efficacy of low dose or no heparinization in cerebral angiography: A randomized controlled study (SELECT trial)

Brain Circulation2024-09-13